Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CAI Caris Life Sciences, Inc.

Pre-Mkt 02-03 04:10:06 EST

23.32

+0.16

+0.69%

High23.84	Low22.80	Vol2.71M
Open22.86	D1 Closing23.16	Amplitude4.49%
Mkt Cap6.58B	Tradable Cap2.14B	Total Shares282.15M
T/O63.01M	T/O Rate2.95%	Tradable Shares91.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":23.32,"timestamp":1770066000000,"preClose":23.16,"halted":0,"volume":2711848,"delay":0,"changeRate":0.0069084628670120956,"floatShares":91917486,"shares":282146923,"eps":-2.417,"marketStatus":"Pre-Mkt","change":0.16,"latestTime":"02-03 04:10:06 EST","open":22.86,"high":23.84,"low":22.8,"amount":63008215.40816,"amplitude":0.044905,"askPrice":24.4,"askSize":200,"bidPrice":20.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.417,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770129000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":23.32,"postHourTrading":{"tag":"盘后","latestPrice":23.29,"preClose":23.32,"latestTime":"19:37 EST","volume":13533,"amount":315581.12,"timestamp":1770079030707,"change":-0.03,"changeRate":-0.001286,"amplitude":0.001715},"volumeRatio":0.9722627155143805,"impliedVol":0.6447,"impliedVolPercentile":0.0903},"requestUrl":"/m/hq/s/CAI","defaultTab":"news","newsList":[{"id":"2608847309","title":"Press Release: AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608847309","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608847309?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:00","pubTimestamp":1770102000,"startTime":"0","endTime":"0","summary":"-- Quarterly revenues increased by 1.7% year-over-year to $62.6 million;Full. year 2025 revenue increased by 1.4% to $245.6 million.-- Quarterly services revenues increased by 1.0% year-over-year to $34.6. million;Full year 2025 services revenues increased by 0.4% to $130.7. -- Quarterly GAAP net income was $1.9 million, or $0.07 per diluted. -- Full year 2025 GAAP net income was $9.0 million, or $0.31 per. quarter and $29.4 million for the full year 2025.EBITDA for the fourth quarter of 2025 was $4.9 million compared to $5.2 million for the fourth quarter of 2024. EBITDA was $18.3 million in 2025 compared to $21.1 million in 2024.On a Non-GAAP basis, EBITDA for the fourth quarter of 2025 was $6.5 million compared to $8.5 million for the fourth quarter of 2024. EBITDA was $24.8 million in 2025 compared to $31.4 million in 2024.On a Non-GAAP basis, net income was $4.5 million, or $0.16 per diluted share, for the fourth quarter of 2025 compared to $11.6 million, or $0.37 per diluted shar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4587","ARR","BK4585","BK4588","AUDC","BK4528","BK4104","CAI","BK4023","BK4020","BK4543","BK4110","BK4551","BK4139"],"gpt_icon":1},{"id":"2608880620","title":"CAI Corp Sets Out Board Line-Up and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2608880620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608880620?lang=en_us&edition=fundamental","pubTime":"2026-02-02 08:39","pubTimestamp":1769992768,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced the current composition of its board of di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-sets-out-board-line-up-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2607013613","title":"CAI Corp Executive Director Chan Cheong Yee to Resign in February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607013613","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607013613?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:16","pubTimestamp":1769764570,"startTime":"0","endTime":"0","summary":"An announcement from China New Economy Fund Ltd. ( ($HK:0080) ) is now available. CAI Corp has announced that executive director Chan Cheong Yee wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-executive-director-chan-cheong-yee-to-resign-in-february-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2606110167","title":"Caris Life Sciences Identifies Key Resistance Mechanisms to Trastuzumab Deruxtecan in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2606110167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606110167?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:31","pubTimestamp":1769607086,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. has published a new study in Nature's npj Breast Cancer journal detailing mechanisms of resistance to trastuzumab deruxtecan  in metastatic breast cancer. The study, which analyzed real-world data from 2,799 T-DXd-treated patients, identified ERBB2  and ABCC1 as key transcriptomic predictors of overall survival specific to T-DXd treatment. Higher ERBB2 expression was associated with improved outcomes, while higher ABCC1 expression correlated with poorer outcomes, independent of HER2 category. The research also found that increased ABCC1 expression and enrichment of mutations in ERBB2, NFE2L2, KEAP1, and TOP1 were present in post-treatment samples, suggesting routes to acquired resistance. The results of this study have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL8B5W6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2606711710","title":"Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan","url":"https://stock-news.laohu8.com/highlight/detail?id=2606711710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606711710?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:30","pubTimestamp":1769607000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUA93BCSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2605122164","title":"CAI Corp. to Seek Shareholder Approval for Equity Transfers, New Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2605122164","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605122164?lang=en_us&edition=fundamental","pubTime":"2026-01-21 12:06","pubTimestamp":1768968366,"startTime":"0","endTime":"0","summary":"CAI Corp.  will hold an extraordinary general meeting on Feb. 10 to seek shareholder approval for two equity transfer agreements involving share issuances, as well as the adoption of a new share scheme, according to a Tuesday Hong Kong bourse filing.Shares of the firm were down more than 1% in Wednesday morning trade.Under the proposals, shareholders will be asked to approve two equity transfer agreements with Longling Capital.The first transaction involves consideration of about HK$52.3 million, to be settled through the issue of up to 145.2 million new shares at an issue price of not less than HK$0.36 per share.The second transaction involves consideration of about HK$19.3 million, to be settled through the issue of up to 53.6 million new shares, also at a minimum issue price of HK$0.36 per share.Separately, the company is seeking approval to adopt a 2026 share scheme, under which the scheme mandate limit will be set at 5% of the total issued shares, excluding treasury shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4215","BK1511","BK4139","BK4104","CAI","00080","BK4585","BK4588","EQR"],"gpt_icon":0},{"id":"2604188151","title":"CAI Corp Calls EGM to Approve Share-Funded Acquisitions From Longling Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2604188151","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604188151?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:10","pubTimestamp":1768911052,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has shared an update. CAI Corp has called an extraordinary general meeting for 10 February 2026 in Hong ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-calls-egm-to-approve-share-funded-acquisitions-from-longling-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2603167745","title":"CAI Corp Reports Unaudited Net Asset Value Per Share of HK$0.14 as of End-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2603167745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603167745?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:39","pubTimestamp":1768466342,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has provided an update. CAI Corp has announced that its unaudited net asset value per share stood at app...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-per-share-of-hk0-14-as-of-end-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2603660439","title":"Could Caris Life Sciences (CAI)–Everlywell Cancer Test Tie-Up Redefine Its Precision Medicine Positioning?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603660439","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603660439?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:32","pubTimestamp":1768465922,"startTime":"0","endTime":"0","summary":"In early January 2026, Caris Life Sciences announced a partnership with digital health company Everlywell to launch Caris Detect, a multi-cancer early detection blood test that applies whole genome sequencing and AI to identify molecular signals of cancer in the bloodstream, with commercialization planned through Everlywell’s platform in the first half of 2026.\nThis collaboration highlights how advanced genomic screening and consumer-focused digital health distribution could broaden access...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cai/caris-life-sciences/news/could-caris-life-sciences-caieverlywell-cancer-test-tie-up-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cai/caris-life-sciences/news/could-caris-life-sciences-caieverlywell-cancer-test-tie-up-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CAI","BK4139","BK4104","BK7104","CAI.AU"],"gpt_icon":0},{"id":"2603625529","title":"Caris Life Sciences Showcases Advances in Precision Oncology and Molecular Diagnostics in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603625529","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603625529?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:50","pubTimestamp":1768254640,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its leadership in precision oncology, molecular diagnostics, and oncology bioinformatics. The company detailed its expanding offerings in early detection, minimal residual disease , and monitoring, as well as its technology-enabled platform supporting more than 6,000 oncologists in the U.S. Caris also reported continued growth in its Precision Oncology Alliance , now comprising 99 member sites—including 46 NCI-designated cancer centers—and providing access to a clinico-genomic dataset of over 740,000 patients. The company supports research, publication, and clinical trial efforts across more than 700 locations, with a network of over 4,000 oncologists. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8JgyHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2602548227","title":"Caris Life Sciences sees Q4 revenue $281M, consensus $204.31M","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548227","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548227?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224987,"startTime":"0","endTime":"0","summary":"An increase of approximately 116% from last year. Completed approximately 52,700 clinical therapy selection cases, an increase of approximately 20%...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-sees-q4-revenue-281m-consensus-204-31m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-sees-q4-revenue-281m-consensus-204-31m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"gpt_icon":0},{"id":"2602996548","title":"Caris Life Sciences Reports Preliminary 116% Revenue Increase for Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2602996548","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602996548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:30","pubTimestamp":1768224659,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The company reported total revenue of approximately $281 million for the fourth quarter of 2025, representing an increase of about 116% compared to the same period in 2024. For the full year, Caris Life Sciences recorded revenue growth of approximately 94%, primarily driven by strong performance in molecular profiling services. These results are subject to change as the company completes its customary year-end close and review procedures. Final audited results will be reported during the company's earnings call in late February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL3zTHM9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2602548988","title":"Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2602548988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602548988?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:30","pubTimestamp":1768224602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA2MWKSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","CAI","BK4139"],"gpt_icon":0},{"id":"2602054819","title":"Caris Life Sciences Inc  FY2025 REV View $724.4 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2602054819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602054819?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:30","pubTimestamp":1768224602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA2MWKSP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2602717510","title":"Caris Life Sciences partners with Everlywell to launch Caris Detect","url":"https://stock-news.laohu8.com/highlight/detail?id=2602717510","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602717510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:15","pubTimestamp":1768223752,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) announced a partnership with Everlywell, a digital health company. Caris and Everlywell are partnering to launch Caris De...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-partners-with-everlywell-to-launch-caris-detect-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-partners-with-everlywell-to-launch-caris-detect-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BK4104","BK4139"],"gpt_icon":0},{"id":"2602510580","title":"Caris Life Sciences Partners with Everlywell to Launch Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510580","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510580?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:02","pubTimestamp":1768222963,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. has announced a partnership with Everlywell to launch Caris Detect, a forthcoming Multi-Cancer Early Detection  blood-based screening assay. Caris Detect leverages whole genome sequencing technology to identify multiple cancer types through the analysis of molecular signals in the bloodstream. Through this collaboration, Caris Detect will be made accessible via Everlywell's consumer-focused digital health platform, aiming to enable earlier and more proactive cancer detection. The assay is expected to launch in the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on January 12, 2026, and is","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL80tRCg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2602433515","title":"3 Stocks Estimated To Be Undervalued By Up To 36.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602433515","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602433515?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:08","pubTimestamp":1768216081,"startTime":"0","endTime":"0","summary":"As the Dow and S&P 500 close at record highs, reflecting a strong start to 2026, investors are keenly observing the broader market dynamics shaped by recent economic indicators and policy developments. In this environment of heightened market performance, identifying undervalued stocks becomes crucial for those looking to capitalize on potential growth opportunities amidst these record-setting indices.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice1-main-header/1585186555515"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/3-stocks-estimated-to-be-undervalued-by-up-to-369","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-au/anglogold-ashanti/news/3-stocks-estimated-to-be-undervalued-by-up-to-369","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0498741114.HKD","LU0498741890.SGD","LU1571399168.USD","LU0345780521.USD","CCNE","BK4077","LU1223082196.USD","VTEX","LU2357305700.SGD","BK4551","AU","BK7050","LU0788108826.HKD","VLY","BK4585","BK4023","HBAN","CAI.AU","CAI","CDE.AU","LU1720051017.SGD","LU2264538146.SGD","ISTR","LU1023059493.AUD","LU0330918003.SGD","LU0154245756.USD","LU0345780281.USD","PERF","CDE","DDOG","LU1064131342.USD","LU0724618789.USD","FITB","BK4549","BK4104","BK4548","BK4561","LU0029874061.USD","MGM","SGHC","BK4116","BK4528","BK4539","BK7104","LU0788109121.HKD","BK4550","LU0154245673.USD","LU1988902786.USD","LU0496367417.USD","BK4533"],"gpt_icon":0},{"id":"2602151317","title":"CAI Corp Delays Circular on Connected Acquisitions and 2025 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2602151317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602151317?lang=en_us&edition=fundamental","pubTime":"2026-01-12 17:40","pubTimestamp":1768210813,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has shared an update. CAI Corp has announced a delay in sending to shareholders a circular related to it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-delays-circular-on-connected-acquisitions-and-2025-share-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-delays-circular-on-connected-acquisitions-and-2025-share-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4139","CAI"],"gpt_icon":0},{"id":"2601688439","title":"Caris Life Sciences to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601688439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601688439?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:31","pubTimestamp":1767619863,"startTime":"0","endTime":"0","summary":"Caris Life Sciences Inc. will present and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California. Caris is scheduled to present on Monday, January 12 at 1:30 PM PT, with live and replay webcasts available on the Investor Relations section of the company’s website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL8vnLs0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2600051108","title":"CAI Corp's CFO Steps Down; Shares Surge 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600051108","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600051108?lang=en_us&edition=fundamental","pubTime":"2026-01-02 15:47","pubTimestamp":1767340030,"startTime":"0","endTime":"0","summary":"CAI Corp's (HKG:0080) chief financial officer, Tai Man Hin Tony, resigned, effective Wednesday, to pursue other career opportunities, according to a same-day Hong Kong bourse filing.Shares of the securities investor were up over 7% in Friday afternoon trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0958},{"period":"1month","weight":-0.1357},{"period":"3month","weight":-0.2521},{"period":"6month","weight":-0.1945},{"period":"1year","weight":0.1105},{"period":"ytd","weight":-0.1357}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}